Öğr. Gör. Dr. Ömer DİLEK

KİŞİSEL BİLGİLER
Ömer DİLEK
Adı Soyadı Öğr. Gör. Dr. Ömer DİLEK
Birimi Rektörlük
Bölüm
Ana Bilim Dalı
Telefon
E-Posta omerdilek@isparta.edu.tr
Kişisel Web Sayfası
Yöksis AkademikYöksis akademik
ORCID ID0000-0003-1409-782X
Akademik Hesaplar
Google ScholarResearchGateResearcherIDScopus Author ID
Bilgilerinizi Personel Bilgi Sistemi'nden (PBS) düzenleyebilirsiniz.
ÖĞRENİM BİLGİLERİ
Lisans SÜLEYMAN DEMİREL ÜNİVERSİTESİ KİMYA BÖLÜMÜ 21.6.2012
Yüksek Lisans SÜLEYMAN DEMİREL ÜNİVERSİTESİ KİMYA (YL) (TEZLİ) 29.7.2015
Doktora SÜLEYMAN DEMİREL ÜNİVERSİTESİ KİMYA (DR) 12.10.2020
YAYINLAR
Sayfada gösterilen bütün veriler YÖK Akademik Bilgi Sisteminden getirilmektedir. YÖK Akademik Bilgi Sistemine girilen veriler 24 saat aralıklarla senkronize edilmektedir. Sayfada gösterilen veriler ile ilgili sorularınız, istekleriniz ve hatalı gösterimler için destek@isparta.edu.tr adresine mail göndererek iletişime geçebilirsiniz.

  • Alanında, uluslararası yayınlanan özgün bilimsel kitapta bölüm ve ünite yazarlığı
  • 1YEŞİL T. A., DİLEK Ö., TİLKİ T. (2025). Kimya Alanında Uluslararası Araştırmalar -II. Eğitim Yayınevi.
  • SCI, SSCI ve AHCI tarafından taranan dergilerde yayımlanan teknik not, editöre mektup, tartışma, vaka takdimi ve özet türünden yayınlar dışındaki makale
  • 1DİLEK Ö. (2025). Comprehensive study of imidazole-based hydrazones: From design, synthesis, and characterization to in vitro and in silico antiproliferative activity analysis. Turkish Journal of Chemistry, 49, 419-438.<a href='https://doi.org/10.55730/1300-0527.3741' target='_blank'>https://doi.org/10.55730/1300-0527.3741</a>
  • 2DİLEK Ö., DÜKEL M., Zarzour F., KARABACAK A. Ç., TİLKİ T. (2025). Structure–activity optimization of Deferasirox–derived aroyl hydrazones: Synthesis, DFT characterization, and mechanistic insights into selective anticancer activity against colon and breast cancer. Bioorganic Chemistry, 165, 109061.<a href='https://doi.org/10.1016/j.bioorg.2025.109061' target='_blank'>https://doi.org/10.1016/j.bioorg.2025.109061</a>
  • 3DİLEK Ö., YEŞİL T. A., TİLKİ T. (2025). Promising Novel Heterocyclic Drug Candidates: Synthesis, Characterization, DFT Calculations and In Silico Investigations of Anticancer Behaviors. Polycyclic Aromatic Compounds, 45, 469-489.<a href='https://doi.org/10.1080/10406638.2024.2409842' target='_blank'>https://doi.org/10.1080/10406638.2024.2409842</a>
  • 4DİLEK Ö., YEŞİL T. A., TİLKİ T., DEDE B. (2025). Design, Synthesis, and Quantum Chemical Calculations of Triazole-Based Aroylhydrazone Molecules: Dual Assessment of Antioxidant Properties via in vitro and in silico Approaches. Journal of Molecular Structure, 1322, 140502.<a href='https://doi.org/10.1016/j.molstruc.2024.140502' target='_blank'>https://doi.org/10.1016/j.molstruc.2024.140502</a>
  • 5DİLEK Ö. (2025). Investigation of Antioxidant Activities of Novel Fluorine-Based Azo Compounds Combined with In Silico Molecular Docking and In Vitro CUPRAC Method. Journal of the Indian Chemical Society, 102, 101513.<a href='https://doi.org/10.1016/j.jics.2024.101513' target='_blank'>https://doi.org/10.1016/j.jics.2024.101513</a>
  • 6YEŞİL T. A., DİLEK Ö., TİLKİ T. (2025). Computational and experimental insights into azo-containing Aroylhydrazones: A promising class of CDK2 inhibitors. Journal of the Indian Chemical Society, 102, 101764.<a href='https://doi.org/10.1016/j.jics.2025.101764' target='_blank'>https://doi.org/10.1016/j.jics.2025.101764</a>
  • 7DİLEK Ö., DEDE B., KARABACAK A. Ç., TİLKİ T. (2024). Promising agent for the efficient extraction of Co(II) ions from aqueous medium and its metal complexes: Synthesis, theoretical calculations and solvent extraction. Polyhedron, 250, 116843.<a href='https://doi.org/10.1016/j.poly.2024.116843' target='_blank'>https://doi.org/10.1016/j.poly.2024.116843</a>
  • 8DİLEK Ö., Patır S., TİLKİ T., ERTÜRK E. (2023). A DDQ-mediated ring-opening and aromatization cascade of a tetrahydrocarbazole-fused tetrahydrofuran for the synthesis of olivacine. Tetrahedron Letters, 124, 154603.<a href='https://doi.org/10.1016/j.tetlet.2023.154603' target='_blank'>https://doi.org/10.1016/j.tetlet.2023.154603</a>
  • 9DİLEK Ö., ERTÜRK E. (2023). Asymmetric transfer hydrogenation of a new N-tosyltetrahydrocarbazole-1-one ester with the Noyori-Ikariya catalyst. ACG Publications, 16, 134-141.<a href='https://doi.org/10.25135/acg.oc2307.2838' target='_blank'>https://doi.org/10.25135/acg.oc2307.2838</a>
  • 10KARABACAK A. Ç., DİLEK Ö., TİLKİ T., DEDE B. (2023). A novel imidazole-based azo molecule: synthesis, characterization, quantum chemical calculations, molecular docking, molecular dynamics simulations and ADMET properties. Journal of Molecular Modeling, 29, 226.<a href='https://doi.org/10.1007/s00894-023-05625-1' target='_blank'>https://doi.org/10.1007/s00894-023-05625-1</a>
  • 11GÜNEY Y., DİLEK Ö., SEZGİN B., TİLKİ T. (2023). Exploring the Potential of Azo Compounds in Leukemia Treatment: Synthesis and Characterization of New Derivatives with Dimedone and Meldrum’s Acid End Groups. ChemistrySelect, 8.<a href='https://doi.org/10.1002/slct.202302642' target='_blank'>https://doi.org/10.1002/slct.202302642</a>
  • 12DİLEK Ö., Patır S., TİLKİ T., ERTÜRK E. (2019). Total Synthesis of Olivacine and Ellipticine via a Lactone Ring-Opening and Aromatization Cascade. The Journal of Organic Chemistry, 84, 7901-7916.<a href='https://doi.org/10.1021/acs.joc.9b00706' target='_blank'>https://doi.org/10.1021/acs.joc.9b00706</a>
  • 13DİLEK Ö., Patır S., ERTÜRK E. (2019). Enantioselective Synthesis of 1- and 4-Hydroxytetrahydrocarbazoles through Asymmetric Transfer Hydrogenation. Synlett, 30, 69-72.<a href='https://doi.org/10.1055/s-0037-1610351' target='_blank'>https://doi.org/10.1055/s-0037-1610351</a>
  • 14DİLEK Ö., Tezeren M. A., TİLKİ T., ERTÜRK E. (2019). Chiral 1,4-aminoalkylphenols for enantioselective diethylzinc addition toaldehydes. TURKISH JOURNAL OF CHEMISTRY, 43, 612-623.<a href='https://doi.org/10.3906/kim-1810-78' target='_blank'>https://doi.org/10.3906/kim-1810-78</a>
  • 15DİLEK Ö., Tezeren M. A., TİLKİ T., ERTÜRK E. (2018). Chiral 2-(2-hydroxyaryl)alcohols (HAROLs) with a 1,4-diol scaffold as a new family of ligands and organocatalysts. Tetrahedron, 74, 268-286.<a href='https://doi.org/10.1016/j.tet.2017.11.054' target='_blank'>https://doi.org/10.1016/j.tet.2017.11.054</a>
  • 16KARABACAK A. Ç., DİLEK Ö. (2014). Synthesis, solvatochromic properties and theoretical calculation of some novel disazo indole dyes. Journal of Molecular Liquids, 199, 227-236.<a href='https://doi.org/10.1016/j.molliq.2014.09.019' target='_blank'>https://doi.org/10.1016/j.molliq.2014.09.019</a>
  • SCI, SSCI ve AHCI dışındaki indeks ve özler tarafından taranan Ulusal dergilerde yayımlanan teknik not, editöre mektup, tartışma, vaka takdimi ve özet türünden yayınlar dışındaki makale
  • 1DİLEK Ö., YEŞİL T. A., TİLKİ T. (2025). A New Candidate for the Treatment of Alzheimers Disease; Synthesis, Characterization, Investigation of Drug Properties with In Silico Methods. Cumhuriyet Science Journal, 46, 62-72.<a href='https://doi.org/10.17776/csj.1487341' target='_blank'>https://doi.org/10.17776/csj.1487341</a>
  • 2DİLEK Ö., DEDE B., KARABACAK A. Ç., TİLKİ T. (2024). Molecular Insights into the Potential Anticancer Property of a Diimine-Diazo Molecule: A Molecular Docking and Molecular Dynamics Simulations Perspective. Hacettepe Journal of Biology and Chemistry, 52, 261-271.<a href='https://doi.org/10.15671/hjbc.1425787' target='_blank'>https://doi.org/10.15671/hjbc.1425787</a>
  • 3DİLEK Ö., TİLKİ T., KARABACAK A. Ç. (2024). Indole-Bearing Azo Compounds: Molecular Docking and in silico ADMET Analysis. Hacettepe Journal of Biology and Chemistry, 52, 129-138.<a href='https://doi.org/10.15671/hjbc.1381196' target='_blank'>https://doi.org/10.15671/hjbc.1381196</a>
  • 4DİLEK Ö. (2024). Imidazole Based Novel Schiff Base: Synthesis, Characterization, Quantum Chemical Calculations, In Silico Investigation of ADMEt Properties and Molecular Docking Simulations against VEGFR2 Protein. Bitlis Eren Üniversitesi Fen Bilimleri Dergisi, 13, 62-78.<a href='https://doi.org/10.17798/bitlisfen.1332971' target='_blank'>https://doi.org/10.17798/bitlisfen.1332971</a>
  • 5YEŞİL T. A., DİLEK Ö., TİLKİ T. (2024). Imidazole and Quinoline-Based Promising Agent for Cancer Treatment; Synthesis, Characterization, and Computational Calculations. Afyon Kocatepe University Journal of Sciences and Engineering, 24, 798-910.<a href='https://doi.org/10.35414/akufemubid.1432554' target='_blank'>https://doi.org/10.35414/akufemubid.1432554</a>
  • 6KILIÇ M., DİLEK Ö. (2023). FMS-TTP-SPE Ön Hazırlık Sistemi Kullanılarak Polisiklik Aromatik Hidrokarbonların Analizi için Yöntem Geliştirilmesi: Yöntemin Isparta İli Gölcük Gölünden Alınan Su Numunelerine Uygulanması. Suleyman Demirel Universitesi Fen Edebiyat Fakultesi Fen Dergisi, 18, 170-180.<a href='https://doi.org/10.29233/sdufeffd.1218334' target='_blank'>https://doi.org/10.29233/sdufeffd.1218334</a>
  • 7YEŞİL T. A., DİLEK Ö., TİLKİ T., YAVUZ M. (2022). Synthesis, Characterization and Investigation of Electrical Conductivity of Poly(2- Oxo-2-Phenyl Ethyl -2-Amino Benzoate)/Bentonite Nanocomposite. Süleyman Demirel Üniversitesi Fen Edebiyat Fakültesi Fen Dergisi, 17, 568-576.<a href='https://doi.org/10.29233/sdufeffd.1148894' target='_blank'>https://doi.org/10.29233/sdufeffd.1148894</a>
  • Uluslararası toplantıda poster, sözlü sunum ile gösterimleri
  • 1YEŞİL T. A., DİLEK Ö., TİLKİ T. (2025). Novel Heterocyclic Aroylhydrazone: Exploring Its Biological Activities With In Silico Methods. 8th International Health Science And Life Congress, Nisan 16-19, Burdur.
  • 2DİLEK Ö., AKKOÇ S., SEZGİN B., BAHAR D., GÜNEY Y., Yılmaz Z. N., Çaylı M., DEDE B., TİLKİ T. (2025). A Novel Heterocyclic Azo-Imine Compound: Synthesis, Characterization, DFT Calculations, nvestigation of Cytotoxic Activities using In Silico and In Vitro Approaches. 13th Internationa Drug Chemistry Conference, Şubat 6-9, Antalya.
  • 3DİLEK Ö., YEŞİL T. A. (2025). Synthesis, Characterization of New Deferasirox Aroylhydrazone, and Solvent Extraction Study to Investigate Its Behavior as an Iron Chelator. 13th International Drug Chemistry Conference, Şubat 6-9, Antalya.
  • 4Doğaner A., TİLKİ T., DİLEK Ö. (2024). Piridin Ve Pirimidin Halkası İçeren Yeni Azo-Hidrazon Bileşiğinin Sentezi, Moleküler Kenetlenme Yöntemiyle Antikanser Aktivitesinin Araştırılması. 6th International Young Researchers Student Congress, Kasım 19-21, Isparta.
  • 5ŞATIR B. G., DİLEK Ö., ERTÜRK E., CUMAOĞLU A. (2019). Evaluation of Carbazole Derivatives as DNA Topoisomerase IIα (TOPIIα) Inhibitor. 7th Drug Chemistry Conference: Design, Synthesis, Production and Standardization of Drug Active Substances, Mart 14-17, Antalya.
  • 6örs y., ŞATIR B. G., DİLEK Ö., ERTÜRK E., CUMAOĞLU A. (2019). Toxicity of the Antitumoral Drug Ellipticine in Prostate Cancer Cell Lines. 7th Drug Chemistry Conference: Design, Synthesis, Production and Standardization of Drug Active Substances, Mart 14-17, ANTALYA.
  • 7Yıldırım M. N. S., ŞATIR B. G., DİLEK Ö., ERTÜRK E., CUMAOĞLU A. (2019). Expression analysis of apoptotic genes by the effect of modified carbazol. 7th Drug Chemistry Conference: Design, Synthesis, Production and Standardization of Drug Active Substances, Mart 14-17, Antalya.
  • Uluslararası toplantıda sunularak özet metin olarak yayımlanan bildiri
  • 1DİLEK Ö. (2024). Heterosiklik Piridazino-karbazol-on Türevi: Sentezi, Karakterizasyonu, Antikanser Aktivitesinin İn siliko ve İn Vitro Yöntemler ile Araştırılması. 7th International Eurasian Conference on Biological and Chemical Sciences (EurasianBioChem 2024), Ekim 2-4, Ankara.
  • Ulusal toplantıda sunularak özet metin olarak yayımlanan bildiri
  • 1DİLEK Ö., Patır S., ERTÜRK E. (2018). Divergent Total Synthesis of Olivacine and Ellipticine. Uluslararası Katılımlı 6. İlaç Kimyası: İlaç Etkin Maddesi Tasarımı, Sentezi, Üretimi ve Standardizasyonu Kongresi, Mart 22-25, Antalya.
  • Ulusal toplantıda poster, sözlü sunum ve gösterim
  • 1DİLEK Ö., ERTÜRK E., BEKCİ H., CUMAOĞLU A. (2018). Eliptisin Olivasin ve Olivasin Türevi 9-Triflorometoksiolivasin’in Androjen Duyarlı (Lncap) ve Androjen Duyarsız (PC-3, DU-145) Prostat Kanseri Hücrelerinde Anti-Proliferatif Etkileri. Uluslararası Katılımlı 6. İlaç Kimyası: İlaç Etkin Maddesi Tasarımı, Sentezi, Üretimi ve Standardizasyonu Kongresiresi, Mart 22-25, Antalya.
  • 2DİLEK Ö., TİLKİ T., ERTÜRK E. (2015). Asimetrik Katılma Reaksiyonları İçin Yeni Kiral Hidroksialkilfenoller. 27. Ulusal Kimya Kongresi, Ağustos 23-28, Çanakkale.

HABERLER

» Tüm Haberler

DUYURULAR

» Tüm Duyurular